Vifor Pharma (United States)
CSL Vifor is a global specialty pharmaceuticals company in the treatment areas of iron deficiency, dialysis, nephrology & rare disease. It is headquartered in Switzerland and consists of CSL Vifor, Vifor Fresenius Medical Care Renal Pharma and Sanifit Therapeutics. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Vifor Pharma (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
184
Total Open
Publications
94
Total
Citations
4.7K
Open Access
Percentage
51%
Total
Publications
184
Total Open
Publications
94
Total
Citations
4.7K
Breakdown
Publisher Open
16%
Both
28%
Other Platform Open
6%
Closed
50%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 49%
39
Hybrid 22%
18
No Guarantees 29%
23
Other Platform Open
Domain 76%
48
Institution 21%
13
Other Internet 19%
12
Preprint 6%
4
Public 3%
2
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 46 |
DOI | Other Internet | 12 |
Europe PMC | Domain | 5 |
Research Square | Preprint | 4 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 4 |
University of Michigan–Ann Arbor | Institution | 3 |
University of Milano-Bicocca | Institution | 1 |
University of Lisbon | Institution | 1 |
University College of Arts Crafts and Design | Institution | 1 |
Universitat Autònoma de Barcelona | Institution | 1 |